✦ LIBER ✦

Impaired immunoglobulin synthesis in multiple myeloma: A B-cell dysfunction

✍ Scribed by A. Carter; I. Silvian; I. Tatarsky; Dr. G. Spira

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 703 KB
Volume: 22
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830220205

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of tumor-specific immunoglobuli

Analysis of tumor-specific immunoglobulin gene rearrangement in peripheral blood B-cells of multiple myeloma patients

✍ Dr. L. Baldini; L. Cro; D. Delia; O. Chiorboli; A. Neri; A. T. Maiolo 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 2 views

Suppression of one monoclonal immunoglob

Suppression of one monoclonal immunoglobulin in the presence of another in multiple myeloma: Evidence for benign B-cell neoplasia

✍ Albert A. Keshgegian 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

Novel evidence of a role for chromosome

Novel evidence of a role for chromosome 1 pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma

✍ Patricia Le Baccon; Dominique Leroux; Christina Dascalescu; Samuel Duley; Daniel 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

## Abstract 1q rearrangement is a remarkably frequent secondary chromosomal change in both non‐Hodgkin's lymphoma (NHL) and multiple myeloma (MM), where it is associated with tumor progression. To gain insight into 1q rearrangement‐associated disease mechanisms, we used fluorescence in situ hybridi

Fine-needle aspiration biopsy of multipl

Fine-needle aspiration biopsy of multiple myeloma in a patient with renal-cell carcinoma: A case report

✍ Dr. Gary L. Cooper; Don W. Shaffer; Hansa B. Raval 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 763 KB

A case of multiple myeloma diagnosed by jine-needle aspiration (FNA) biopsy and confirmed by laboratory studies in a patient with a history of renal-cell carcinoma ispresented. The patient was diagnosed with renal-cell carcinoma of the right kidney and a radical nephrectomy was performed. Eighteen m

The defect in peripheral blood B-cell ac

The defect in peripheral blood B-cell activation in patients with multiple myeloma is not due to a deficiency in the production of B-cell growth and differentiation factors

✍ Thérèse Commes; Bernard Klein; Michel Jourdan; Gisèle Clofent; Frédéric Houssiau 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 973 KB

A novel NF-κB inhibitor DHMEQ selectivel

A novel NF-κB inhibitor DHMEQ selectively targets constitutive NF-κB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo

✍ Mariko Watanabe; Md. Zahidunnabi Dewan; Takamitu Okamura; Masataka Sasaki; Kinji 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 453 KB

Multiple myeloma (MM) is a fatal lymphoid malignancy that is incurable with conventional modalities of chemotherapy. Strong and constitutive activation of nuclear factor kappa B (NF-kappaB) is a common characteristic of MM cells. In our study we successfully target NF-kappaB with a novel NF-kappaB i